Paper · 42278221
Potential Association of BRAF and PIK3CA Copy Number Alterations with Long-Term Survival in IDH-Wildtype Glioblastoma: A Pilot Study.
Tomoszková S and 6 others. Int J Mol Sci, 2026. Cited by 0 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Potential Association of BRAF and PIK3CA Copy Number Alterations with Long-Term Survival in IDH-Wildtype Glioblastoma: A Pilot Study. Papers, record 42278221. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42278221
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Potential Association of BRAF and PIK3CA Copy Number Alterations with Long-Term Survival in IDH-Wildtype Glioblastoma: A Pilot Study.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Proto-Oncogene Proteins B-raf | Major topic |
| Glioblastoma | Major topic |
| Class I Phosphatidylinositol 3-Kinases | Major topic |
| Isocitrate Dehydrogenase | Major topic |
| Brain Neoplasms | Major topic |
| DNA Copy Number Variations | Major topic |
| Humans | |
| Pilot Projects | |
| Female | |
| Male | |
| Middle Aged | |
| Mutation | |
| Aged | |
| DNA Methylation | |
| Adult | |
| Retrospective Studies | |
| DNA Modification Methylases | |
| Prognosis | |
| Tumor Suppressor Proteins | |
| DNA Repair Enzymes |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| MH CZ - DRO - FNOs/2023 | Ministry of Health Czech Republic | PubMed | ||
| CZ.10.03.01/00/22_003/0000003 | European Union | PubMed |
Source PubMed
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References21
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28,534,272 | BRAF Mutation is Associated with an Improved Survival in Glioma-a Systematic Review and Meta-analysis. | Mol Neurobiol | 2018 | https://conductscience.org/library/papers/28534272 | PubMed |
| 2 | 37,216,120 | A novel IRE1 kinase inhibitor for adjuvant glioblastoma treatment. | iScience | 2023 | https://conductscience.org/library/papers/37216120 | PubMed |
| 3 | 1,565,476 | B-raf and a B-raf pseudogene are located on 7q in man. | Oncogene | 1992 | https://conductscience.org/library/papers/1565476 | PubMed |
| 4 | 19,305,151 | PIK3CA mutations in human solid tumors: role in sensitivity to various therapeutic approaches. | Cell Cycle | 2009 | https://conductscience.org/library/papers/19305151 | PubMed |
| 5 | 30,351,999 | BRAF Inhibition in BRAFV600-Mutant Gliomas: Results From the VE-BASKET Study. | J Clin Oncol | 2018 | https://conductscience.org/library/papers/30351999 | PubMed |
| 6 | 29,295,876 | Rapid Clinical and Radiographic Response With Combined Dabrafenib and Trametinib in Adults With BRAF-Mutated High-Grade Glioma. | J Natl Compr Canc Netw | 2018 | https://conductscience.org/library/papers/29295876 | PubMed |
| 7 | 17,050,665 | PIK3CA gene mutations in pediatric and adult glioblastoma multiforme. | Mol Cancer Res | 2006 | https://conductscience.org/library/papers/17050665 | PubMed |
| 8 | 36,003,762 | Prediction of BRAF mutation status in glioblastoma multiforme by preoperative ring enhancement appearances on MRI. | Front Oncol | 2022 | https://conductscience.org/library/papers/36003762 | PubMed |
| 9 | 36,686,797 | Implications of BRAF V600E mutation in gliomas: Molecular considerations, prognostic value and treatment evolution. | Front Oncol | 2022 | https://conductscience.org/library/papers/36686797 | PubMed |
| 10 | 33,677,887 | [Epithelioid glioblastoma with BRAF V600E mutation: a clinicopathological and molecular study]. | Zhonghua Bing Li Xue Za Zhi | 2021 | https://conductscience.org/library/papers/33677887 | PubMed |
1 to 10 of 21
See all 21 referencesCited by0
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
None in this release.
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ATRX | 546 | PubTator's text mining | https://conductscience.org/library/genes/546 | NCBI Gene |
| BRAF | 673 | PubTator's text mining | https://conductscience.org/library/genes/673 | NCBI Gene |
| EGFR | 1,956 | PubTator's text mining | https://conductscience.org/library/genes/1956 | NCBI Gene |
| IDH1 | 3,417 | PubTator's text mining | https://conductscience.org/library/genes/3417 | NCBI Gene |
| MGMT | 4,255 | PubTator's text mining | https://conductscience.org/library/genes/4255 | NCBI Gene |
| PIK3CA | 5,290 | PubTator's text mining | https://conductscience.org/library/genes/5290 | NCBI Gene |
| TERT | 7,015 | PubTator's text mining | https://conductscience.org/library/genes/7015 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42278221
GET https://conductscience.org/api/papers/v1/42278221/references?page=2